Correlation Between NRX Pharmaceuticals and EFFECTOR Therapeutics
Can any of the company-specific risk be diversified away by investing in both NRX Pharmaceuticals and EFFECTOR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NRX Pharmaceuticals and EFFECTOR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NRX Pharmaceuticals and EFFECTOR Therapeutics, you can compare the effects of market volatilities on NRX Pharmaceuticals and EFFECTOR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NRX Pharmaceuticals with a short position of EFFECTOR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NRX Pharmaceuticals and EFFECTOR Therapeutics.
Diversification Opportunities for NRX Pharmaceuticals and EFFECTOR Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between NRX and EFFECTOR is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding NRX Pharmaceuticals and EFFECTOR Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on EFFECTOR Therapeutics and NRX Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NRX Pharmaceuticals are associated (or correlated) with EFFECTOR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of EFFECTOR Therapeutics has no effect on the direction of NRX Pharmaceuticals i.e., NRX Pharmaceuticals and EFFECTOR Therapeutics go up and down completely randomly.
Pair Corralation between NRX Pharmaceuticals and EFFECTOR Therapeutics
If you would invest 150.00 in NRX Pharmaceuticals on December 20, 2024 and sell it today you would earn a total of 68.00 from holding NRX Pharmaceuticals or generate 45.33% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
NRX Pharmaceuticals vs. EFFECTOR Therapeutics
Performance |
Timeline |
NRX Pharmaceuticals |
EFFECTOR Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
NRX Pharmaceuticals and EFFECTOR Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with NRX Pharmaceuticals and EFFECTOR Therapeutics
The main advantage of trading using opposite NRX Pharmaceuticals and EFFECTOR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NRX Pharmaceuticals position performs unexpectedly, EFFECTOR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EFFECTOR Therapeutics will offset losses from the drop in EFFECTOR Therapeutics' long position.NRX Pharmaceuticals vs. Biomx Inc | NRX Pharmaceuticals vs. Lexaria Bioscience Corp | NRX Pharmaceuticals vs. Aditxt Inc | NRX Pharmaceuticals vs. Nutriband |
EFFECTOR Therapeutics vs. Celularity | EFFECTOR Therapeutics vs. Humacyte | EFFECTOR Therapeutics vs. NRx Pharmaceuticals | EFFECTOR Therapeutics vs. Reviva Pharmaceuticals Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |